by Rajesh Kothari, CFA
Managing Director & Healthcare Practice Lead Cascade Partners
by Gary Sandhu
Vice President & Personal Injury Practice Cascade Partners
Clinical neurology is rapidly becoming one of the most dynamic, and investable, areas in U.S. healthcare. Driven by rising rates of neurological disease, shifting patient expectations, and a wave of new therapies, the specialty is seeing sustained demand and strong interest from both providers and investors.
The clinical neurology industry’s positive growth trajectory is based on the following:
A Growing Burden of Neurological Disease
Neurological disorders are increasing at an alarming pace, placing new pressure on an already stretched healthcare system. Stroke incidence has climbed nearly 8% over the past decade, while the number of Americans living with the long-term effects of stroke has surged by more than 80%. Alzheimer’s disease now affects over seven million people (up 55% since 2000) and Parkinson’s cases are expected to reach 1.2 million by 2030 according to the Alzheimer’s Association.
The economic impact is staggering: dementia-related care costs are projected to rise from $384 billion in 2025 to nearly $1 trillion by 2050. These trends, cited by the Alzheimer’s Association, highlight the growing need for expanded clinical capacity, better coordination of care, and more efficient treatment models.
Evolving Practice Models: Care That Meets Patients Where They Are
As patients demand more convenient, continuous care, neurology practices are evolving. The most progressive practices are embracing “one-stop-shop” models that integrate various specialists to support neurology disorders as well as supporting ancillary services including imaging, infusion, and behavioral health services under one roof. This approach enhances diagnostic accuracy, improves patient experience, and supports participation in value-based reimbursement programs.
Outpatient and home-based infusion therapy are also on the rise, Precedence Research projects they’ll reach nearly $38 billion by 2034, while ambulatory care centers could top $52 billion. For practices that adapt, these services present significant growth opportunities to improve outcomes and diversify revenue.
Workforce Challenges and the Push for Efficiency
Neurology faces one of healthcare’s most pressing capacity challenges: a projected 19% shortfall in neurologists and patient wait times that regularly exceed two months, according to the American Academy of Neurology. To meet growing demand, practices are expanding the use of advanced practice providers (APPs), telehealth, and workflow optimization tools.
Most neurology practices remain small, often just one to three physicians, leaving room for greater scale and operational efficiencies. Practices that can streamline processes and expand access are well-positioned to lead in this environment.
Innovation Driving a Robust Research Pipeline
Clinical Trial Starts by Therapeutic Area
M&A Momentum: A Fragmented Market with Room to Scale
Despite its growth potential, U.S. neurology remains highly fragmented, with no national platforms comparable to those in cardiology, dermatology, or gastroenterology. That landscape is beginning to change. More than 15 neurology practices have been acquired or invested in over the past five years, most involving infusion or diagnostics services.
Private equity–backed specialty platforms are now eyeing neurology as the next logical extension, pursuing vertical integration to capture higher-margin ancillary services and improve patient access. With U.S. medicine spending projected to increase by $116 billion from 2024 to 2029, according to IQVIA, much of it tied to biologics and novel therapies, neurology offers a clear opportunity to replicate successful consolidation strategies from adjacent specialties.
Outlook: An Inflection Point for Growth
With patient demand surging, innovation accelerating, and consolidation just beginning, neurology stands at a critical turning point. Practices that embrace integrated care delivery, operational scalability, and strategic investment partnerships will be best positioned for success.
The U.S. neurology services market is expected to grow at an annual rate of 8.3% through 2034, as reported by Precedence Research, a trajectory that underscores both the clinical significance and the investment potential of this specialty.
Check out our Clinical Neurology Industry Market Update Report here:
Clinical Neurology Industry Market Update